跳至主要内容
临床试验/NCT00636844
NCT00636844已完成不适用

Detection of Chemotherapy Induced Cardiotoxicity

George Washington University1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
1
主要终点
The genetic profile of patients with anthracycline-induced elevation of troponin-I

研究概览

简要总结

To identify patients that are at risk of heart damage after receiving chemotherapy (adriamycin).

详细描述

To identify patients at risk of development of heart damage after receiving chemotherapy by obtaining the genetic profile of those who show: elevation of troponin, left ventricular systolic and diastolic dysfunction, and pro-oxidant stress markers.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • undergoing anthracycline and/or trastuzumab therapy for the first time

排除标准

  • abnormal ventricular ejection fraction
  • past history of, or active cardiac disease including: MI, CHF, angina, arrhythmia requiring medication, valvular disease, uncontrolled systemic hypertension

结局指标

主要结局

The genetic profile of patients with anthracycline-induced elevation of troponin-I

时间窗: one year

次要结局

  • Assess the genetic profile of patient with anthracycline-induced left ventricular systolic and diastolic dysfunction(one year)
  • Assess the relationship of quantitative increases of pro-oxidant stress and a specific genetic profile(one year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验